The August 2013 edition of the Transplant Trial Watch is now available online, and via our iPhone, iPad and Android app. This month, trials include Mizoribine in renal transplantation, retroperitoneoscopic donor nephrectomy and biopsy reporting following lung transplant.
The May 2013 edition of the Transplant Trial watch is now available on the CET website and our Trial Watch app for iPhone, iPad and Android. This month, trials include long-term follow-up of steroid avoidance in liver transplantation, the eternal question of T-tubes following liver transplant and mizoribine in renal transplantation.
There is an interesting editorial in this month’s Transplantation discussing the exclusion of elderly patients from clinical trials. Such practice clearly has an impact on the generalisability of the results of trials to an increasingly ageing transplant population (the proportion of US kidney transplant recipients aged 65 or over doubled from 7% to 16% between […]
The April 2013 edition of the Transplant Trial Watch is now available on the CET website. Each month, CET staff select 10 important RCTs in the field of transplantation, summarise the findings and assess trial quality. This month, trials include vildagliptin and pioglitazone for post-transplant glucose intolerance, sirolimus in transplant patients with squamous cell carcinoma […]
The March 2013 edition of the Transplant Trial Watch is now available on the CET site and via our app for iPhone, iPad and Android. This month, trials include epidural anaesthesia in renal transplantation, pharmacodynamic monitoring of tofacitinib and the association between inflammatory markers and response to CMV treatment.
Happy New Year to all of our readers! The January 2013 edition of the Transplant Trial is now available, with 10 recently published trials in the field of solid organ transplantation selected and appraised for quality. This month, there are results of pre-transplant antiviral therapy in liver transplantation, intensive insulin therapy in diabetic renal transplant […]
This is a very interesting study in which 500 board certified internists were presented with abstracts that described a clinical trial of three hypothetical drugs. The trials had a high, a medium or a low level of quality and each report had included a disclosure about the source of funding, either from a pharmaceutical company, […]
The October edition of the Transplant Trial Watch is now available on the CET website. Each month, our team summarise and assess the quality of 10 important randomised controlled trials in the field of solid organ transplantation. This month, trials include sirolimus in the prevention of skin cancer in transplant recipients, machine perfusion in extended […]